Avalon GloboCare Files 8-K: Regulation FD & Exhibits
Ticker: ALBT · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1630212
Sentiment: neutral
Topics: disclosure, regulatory
Related Tickers: AVCO
TL;DR
AVCO filed an 8-K on April 15th for Reg FD and exhibits. Details pending.
AI Summary
On April 15, 2025, Avalon GloboCare Corp. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Avalon GloboCare Corp. is providing updates or disclosures required by the SEC, which could contain important information for investors.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not appear to contain any immediately negative or positive material information.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- April 15, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-38728 (filing_id) — Commission File Number
- 47-1685128 (ein) — I.R.S. Employer Identification Number
- 4400 Route 9 South, Suite 3100, Freehold, NJ 07728 (address) — Principal executive offices
- (732) 780-4400 (phone_number) — Registrant's telephone number
FAQ
What specific information is being disclosed under Regulation FD?
The provided excerpt does not detail the specific information disclosed under Regulation FD, only that it is a category of the filing.
What types of financial statements and exhibits are included in this filing?
The excerpt states that 'Financial Statements and Exhibits' are included, but does not specify their nature or content.
Has Avalon GloboCare Corp. undergone any recent name changes?
Yes, the company was formerly known as Avalon Globocare Corp. (name change effective October 18, 2016) and prior to that, GLOBAL TECHNOLOGIES CORP (name change effective January 8, 2015).
What is the primary business of Avalon GloboCare Corp. according to the filing?
The filing lists the Standard Industrial Classification as 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
Where are Avalon GloboCare Corp.'s principal executive offices located?
The principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Avalon GloboCare Corp. (ALBT).